Viewing StudyNCT06494527



Ignite Creation Date: 2024-07-17 @ 11:38 AM
Last Modification Date: 2024-10-26 @ 3:34 PM
Study NCT ID: NCT06494527
Status: NOT_YET_RECRUITING
Last Update Posted: 2024-07-11
First Post: 2024-07-02

Brief Title: A Phase 1 Study to Evaluate the SafetyTolerability PKPD of RG002C0106 Injection in Healthy Adults
Sponsor: Rigerna Therapeutics Beijing Rigerna Therapeutics Suzhou Rigerna OA Therapeutics Pty Ltd
Organization: Rigerna Therapeutics Beijing Rigerna Therapeutics Suzhou Rigerna OA Therapeutics Pty Ltd

Key Dates - Follows AllAPIJSON File Order

Start Date: 2024-08-09
Start Date Type: ESTIMATED
Primary Completion Date: 2025-10-20
Primary Completion Date Type: ESTIMATED
Completion Date: 2025-12-31
Completion Date Type: ESTIMATED
First Submit Date: 2024-07-02
First Submit QC Date: None
Study First Post Date: 2024-07-10
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2024-07-10
Last Update Post Date: 2024-07-11
Last Update Post Date Type: ACTUAL